Ozempic and Wegovy may raise hair loss risk in some men
محرر واقع مصر
ساينس ديلي - الكل
13 سبتمبر, 2026
GLP-1 drugs such as Ozempic, Wegovy, and Zepbound may increase hair-loss risk by 7% in men who are already genetically susceptible to male-pattern baldness. The findings suggest thinning hair may not be caused only by rapid weight loss and could also reflect a biological link between GLP-1 activity and hair follicles.
